About the Authors

Lena Backlund

lena.backlund@sll.se

Affiliation Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

Catharina Lavebratt

Affiliations Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden

Louise Frisén

Affiliations Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden, Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden

Pernilla Nikamo

Current address: Dermatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

Affiliations Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden

Dzana Hukic Sudic

Affiliations Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden

Lil Träskman-Bendz

Affiliation Department of Clinical Sciences, University Hospital, Lund, Sweden

Mikael Landén

Affiliations Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden, Institution of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University, Sweden

Gunnar Edman

Affiliations Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden, Department of Psychiatry, Tiohundra AB, Norrtälje, Sweden

Marquis P. Vawter

Affiliation Functional Genomics Laboratory, Department of Psychiatry and Human Behavior, School of Medicine, University of California Irvine, Irvine, California, United States of America

Urban Ösby

Affiliations Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden, Department of Psychiatry, Tiohundra AB, Norrtälje, Sweden

Martin Schalling

Affiliations Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden

Competing Interests

The authors have read the journal's policy and have the following conflicts: LB has received consultancy fees from Bristol-Myers Squibb and has been reimbursed by Eli Lilly and Bristol-Myers Squibb for attending conferences and presenting lectures. UÖ has received grant/research support from Bristol-Myers Squibb and Janssen-Cilag and has been a consultant for or received fees for speaking and attending conferences from AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Pfizer. GE has been a consultant for AstraZeneca and Janssen-Cilag and his wife is a shareholder of AstraZeneca. ML has been reimbursed by Eli Lilly, AstraZeneca and Wyeth for lectures, serves on advisory boards for AstraZeneca and Lundbeck, and has received research grants from AstraZeneca. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: LB CL LF PN UÖ MPV MS. Performed the experiments: CL PN MPV DSH. Analyzed the data: LB CL PN DSH GE MPV. Contributed reagents/materials/analysis tools: LB LF UÖ LTB ML MPV MV MS. Wrote the paper: LB CL PN LTB ML MS UÖ GE MPV DZH MS.